New hopes – Gearing up for new year ahead

The year 2021 created the greatest learning for humankind and caused a huge disruption in mobility and adoption of digital technology and tools. It was a more challenging year than 2020 as the healthcare sector across the world has been pushed to the brink in terms of overburdening the patient load and dealing with highly infectious viruses. Healthcare will remain in focus and the mainstream of discussion will be medical devices, healthcare delivery, and pharmaceuticals through 2022 as well. Trivitron Healthcare has a positive outlook for 2022 and will focus on creating new innovations that play a significant role in healthcare.

Trivitron Healthcare has been through many developments in medical imaging, IVD, newborn screening, critical care, and radiation protection. With new and a few upgraded international research ventures, I am sure we are on the path to becoming an organization led by science and technology to deliver the best healthcare services across the globe.

We plan to leverage the functioning of our commercial and R&D capabilities so as to emerge as the top destination for advanced healthcare and revolutionary medical technologies. We are committed to bringing new and advanced technology platforms on board following the latest research in genomics, proteomics, new generation sequencing, and mass spectrometry. Labsystem Diagnostics, our international manufacturing unit in Finland, is a pioneer in diagnostic research and development and is a leader in newborn screening and diagnostic products. They are expanding their portfolio of qualitative and quantitative mass spectrometry solutions to revolutionize medical testing.

At our research center in Vienna, Austria, the core focus of our scientists is to use innovation to deliver exceptional products in the field of IVD. At Bome Trivitron Turkey, our manufacturing relies on precision with the integration of high technology and the latest R&D to bring diversity, technology, and technical excellence in the field of IVD.

In our medical imaging portfolio, we have been setting new trends in the Indian and international markets by introducing new and advanced products. Our Felicia Mammography (digital & analogue) is a potent novelty that offers high-quality patient care by offering diagnostic confidence to the user. We have also introduced, the SonoRad ultrasound series, which offers a comprehensive range of color doppler systems equipped with an intelligent, powerful tool to deliver a precise diagnosis.

We strive to bring new healthcare innovations keeping an eye on future requirements and focusing on R&Ds by integrating new technology to make healthcare accessible and cost-effective for all. The field of radiology in India has advanced tremendously, and it is a proud moment to share that Trivitron Healthcare is launching its advanced, high-quality, and cost-effective CT scanner to improvise scenarios of medical imaging and diagnostics.

The Indian healthcare sector is full of opportunities for medical devices and the diagnostic industry and Trivitron is one of the leading destinations that offer advanced healthcare devices, products, and facilities catering to a greater proportion of the population around the globe at the best cost without compromising the quality. We focus on Make in India products and this will accelerate the growth of the country’s manufacturing sector.

At Trivitron, it goes without saying that our employees come first, and our relationship with them grows stronger with every passing day, especially in times of difficulty and challenge. By speaking the language of care, we dream to create a healthy world where everyone can achieve equitable access to quality and affordable healthcare solutions. To meet the ever-changing technological advancements and to bridge the gap in healthcare, Trivitron Healthcare is committed to bringing new and advanced technology platforms on board and expanding more every day to meet the ever-increasing demand for novel innovations to improve health.

At Trivitron Healthcare, delivering the best healthcare services is at the heart of everything we do, and we will continue to put our efforts, resources, and investments into medical imaging, diagnostics, and other segments of healthcare, for better prevention and early screening of disease. Our objective for the year 2022 is to deliver better healthcare services and create a healthy, blissful world by speaking the language of care.